| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/25/2000 | US6054133 Anti-microbial targeting for intracellular pathogens |
| 04/25/2000 | US6054132 A purified toxin in diagnostic testing for detecting peptic ulceration and gastric malignancy, and as a vaccine for providing immunologic protection against bacterial infection |
| 04/25/2000 | US6054131 Vaccine composition for herpes simplex virus and method of using |
| 04/25/2000 | US6054130 Non-splicing variants of gp350/220 |
| 04/25/2000 | US6054126 A synthetic polypeptide containing the conformational epitope recognized by monoclonal antibody mab 17-82 for neutralizing antibodies in an avian host; stimulating an immune response against infectious bursal disease virus in poultry |
| 04/25/2000 | US6054123 Haemophilus influenzae dimethylsulphoxide reductase enzyme |
| 04/25/2000 | US6054115 Purifying by exposing a mixture of uncoordinated hydroxyalkyl phosphine groups and coordinated hydroxyalkyl phosphine groups to an amine to separate the unbound coordinated groups from the bound uncoordinated groups |
| 04/25/2000 | CA2196538C Process for making antimicrobial compounds |
| 04/25/2000 | CA2177990C Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation |
| 04/25/2000 | CA2098021C Composition used as a therapeutic agent against chronic viral hepatic diseases |
| 04/22/2000 | CA2285749A1 Novel proteins from actinobacillus pleuropneumoniae |
| 04/20/2000 | WO2000022430A2 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000022135A1 Helicobacter pylori vaccine |
| 04/20/2000 | WO2000022134A2 Test kit for diagnosis of borrelia infection and novel borrelia antigens for the development of vaccines |
| 04/20/2000 | WO2000022113A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 04/20/2000 | WO2000022112A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 04/20/2000 | WO2000021964A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and anfiinflammatory activity |
| 04/20/2000 | WO2000021963A1 Il-8 receptor antagonists |
| 04/20/2000 | WO2000021961A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 04/20/2000 | WO2000021960A1 Heterocyclyl amino methyloxa zolidinones as antibacterials |
| 04/20/2000 | WO2000021959A1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 04/20/2000 | WO2000021955A1 Quinazoline derivatives |
| 04/20/2000 | WO2000021952A1 Quinoline derivatives and their use as antibacterial agents |
| 04/20/2000 | WO2000021948A1 Naphthrydine compounds and their azaisosteric analogues as antibacterials |
| 04/20/2000 | WO2000021942A1 Azadioxacycloalkene derivatives, methods for the production thereof and their use as fungicides and pest control agents |
| 04/20/2000 | WO2000021565A1 Selective eradication of virally-infected cells by combined use of a cytotoxic agent and an antiviral agent |
| 04/20/2000 | WO2000021558A1 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 04/20/2000 | WO2000021557A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | WO2000021556A1 Anti hiv compositions comprising immunostimulatory polynucleotides and hiv antigens |
| 04/20/2000 | WO2000021546A1 Preventives/remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters |
| 04/20/2000 | WO2000021544A1 Ups (undecaprenyl diphosphate synthase) |
| 04/20/2000 | WO2000021538A1 A method of modulating ion channel functional activity |
| 04/20/2000 | WO2000021530A1 Peripherally acting anti-pruritic opiates |
| 04/20/2000 | WO2000021509A2 Methods of treatment |
| 04/20/2000 | WO2000021368A1 Hydroxystilbene compounds used as microbicidal active substances |
| 04/20/2000 | WO2000005245A3 Inhibitors of urokinase and blood vessel formation |
| 04/20/2000 | WO2000003745A3 Polysaccharide vaccine for staphylococcal infections |
| 04/20/2000 | WO1999066917A3 Composition comprising ss-hydroxy-ss-methylbutyric acid and at least one amino acid |
| 04/20/2000 | WO1999066065A3 Proteasomal activity |
| 04/20/2000 | WO1999059630A9 Type iii bordetella secretion system |
| 04/20/2000 | WO1999058658A3 Expression vectors for stimulating an immune response and methods of using the same |
| 04/20/2000 | WO1999008691A8 Use of locally delivered metal ions for treatment of periodontal disease |
| 04/20/2000 | DE19847823A1 New 3-(Hetero)aryl-5-aminosulfonyl-1,2,4-thiadiazole derivatives useful as inhibitors of IL-1beta production in treatment of e.g. leukemia, septic shock, hepatitis, AIDS and diseases of locomotor system |
| 04/20/2000 | DE19847628A1 Outer membrane protein of Helicobacter pylori and DNA sequences, useful in vaccines and for production of diagnostic or therapeutic antibodies |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2346713A1 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | CA2346542A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and antiinflammatory activity |
| 04/20/2000 | CA2346464A1 Peripherally acting anti-pruritic opiates |
| 04/20/2000 | CA2346414A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 04/20/2000 | CA2346155A1 Enzymatic synthesis of ssdna |
| 04/20/2000 | CA2346122A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 04/20/2000 | CA2346006A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | CA2344558A1 Anti hiv compositions comprising immunostimulatory polynucleotides and hiv antigens |
| 04/20/2000 | CA2342623A1 Heterocyclylaminomethyloxazolidinones as antibacterials |
| 04/19/2000 | EP0994120A1 Process to remove lipopolysaccharides from aqueous solution of proteins |
| 04/19/2000 | EP0993830A2 New stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation |
| 04/19/2000 | EP0993483A1 Conjugate of polyethylene glycol and chitosan |
| 04/19/2000 | EP0993462A1 Calixarene tubes as cation receptors |
| 04/19/2000 | EP0993449A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
| 04/19/2000 | EP0713487B1 Novel quinolone carboxylic acid derivatives |
| 04/19/2000 | EP0711297B1 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity |
| 04/19/2000 | EP0668769B1 Synthetic compositions related to oak bark extrakt, and method of using same |
| 04/19/2000 | EP0666862B1 6-(substituted methylene) penems and intermediates |
| 04/19/2000 | CN1251129A Use of antibacterial active substance triclocarbance in liquid soaps |
| 04/19/2000 | CN1251101A Salt of naphthyridine carobxylic acide derivative |
| 04/19/2000 | CN1251098A Pyrrole compounds, their prodn. and their use |
| 04/19/2000 | CN1251042A Identification of broadly reactive DR restricted epitopes |
| 04/19/2000 | CN1251041A Fine tuned progegrins |
| 04/19/2000 | CN1250776A Heterodicyclic compound derivatives |
| 04/19/2000 | CN1250668A Stable protein compositions |
| 04/19/2000 | CN1250652A Compositions contg. benzoxazinone and nucleoside like materials |
| 04/19/2000 | CN1051560C Method for preparing chelate of antibiotic and complex metallic salt |
| 04/19/2000 | CN1051559C Novel aminooligosaccharide derivative and process for preparing same |
| 04/19/2000 | CN1051550C 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopntene-1-methanol succinate as antiviral agent |
| 04/19/2000 | CN1051548C Heterobicyclic derivatives, pharmaceutical compositions contg. same, mfg. method and use thereof |
| 04/19/2000 | CN1051547C Beta-lactams derivative and its prepn.and use |
| 04/19/2000 | CN1051470C Medicine for curing viral hepatitis |
| 04/18/2000 | US6051716 Antimicrobial agents |
| 04/18/2000 | US6051703 Broad spectrum antibiotic |
| 04/18/2000 | US6051691 Amino acid sequence of protein; for screening bactericides and bacteristats especially targeted to streptococci |
| 04/18/2000 | US6051613 Nitrogen monoxide production suppressor |
| 04/18/2000 | US6051584 Viricides; fungicides; bactericides |
| 04/18/2000 | US6051579 Viricide for herpes virus |
| 04/18/2000 | US6051569 1'S, 5R, 6R-carbapenem derivatives and antimicrobial agents comprising the same |
| 04/18/2000 | US6051563 Methods for the administration of amifostine and related compounds |
| 04/18/2000 | US6051416 Methods for producing enhanced antigenic Helicobacter sp. |
| 04/18/2000 | US6051404 A nucleic acid encoding a protein; vaccines for poultry |
| 04/18/2000 | US6051375 Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses |
| 04/18/2000 | US6051255 Polymer coated tablet comprising amoxycillin and clavulanate |
| 04/18/2000 | US6051252 Compacted ribavirin composition substantially free of other ribavirin polymorphic forms. |
| 04/18/2000 | US6051240 Separating culture into cells and supernatant; concentrating supernatant; contacting with calcium ions in presence of phosphate ions to form calcium phosphate gel; separating gel to recover supernatant; contacting with ion exchange gel |
| 04/18/2000 | US6051239 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 04/18/2000 | US6051238 Stabilizers for lyophilized mumps vaccines |
| 04/18/2000 | US6051234 Health diet for preventing diseases caused by life-habit |
| 04/18/2000 | US6051227 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 04/18/2000 | CA2092195C Retroviral packaging cell line |
| 04/18/2000 | CA1340961C 2', 3' - dideoxy - 2' - fluoronucleosides |
| 04/13/2000 | WO2000020645A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF TUMOR NECROSIS FACTOR-α (TNF-α) EXPRESSION |
| 04/13/2000 | WO2000020609A2 Protective recombinant haemophilus influenzae high molecular weight proteins |